Tribune Therapeutics AB
559281-1045ActiveDeveloping novel medicines to halt fibrotic disease progression across organs.
Preclinical Biopharmaceutical Companytribunetx.com
Yleiskatsaus
- 1–4
- Työntekijät
- ≤1t SEK
- Liikevaihto
- 2020
- Perustettu
Avainpäättäjät
Georg Vo Beiske
CEO
Ole J. Kaasbøll
CSO, Co-founder
Berthold Bödeker
CTO
Mathias Locher
CDO
Kuvaus
Tribune Therapeutics is a preclinical biopharmaceutical company established in 2020, focused on creating novel medicines for treating fibrosis. Their core mission is to address fibrotic diseases regardless of the underlying cause or affected tissue, such as the heart, kidneys, or lungs. The company'...
CALLUNA PHARMA AS